Here, based on a small series of cases undergoing targeted sequencing for clinical purposes, we have shown that TP53 structural rearrangements are an unexpectedly common cause of TP53 inactivation in advanced prostatic carcinomas. Here, TP53 is linked to prostate carcinoma.